|
Status |
Public on Dec 01, 2023 |
Title |
Gastrointestinal B-cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcRγ signaling |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Purpose: Aim of the study was to identify transcriptional changes in the intestinal B cells of NASH-affected mice versus healthy mice. Results: RNA-Seq analysis in both sorted CD19+/CD20+ and sorted B220+ cells, revealed increased expression levels in genes involved in lipid metabolism, and in antigen presentation, BCR signaling, B cells activation and proliferation. Conclusion: Mice bearing NASH (both WT and μMT choline-deficient high-fat diet (CD-HFD) fed mice) display altered B cells in the gastrointestinal tract towards an activated phenotype and increased proliferation induced by the CD-HFD.
|
|
|
Overall design |
RNAseq analysis of sorted CD19+/CD20+ and of B220+ cells from small intestines of WT normal diet (ND), WT CD-HFD, and μMT CD-HFD fed mice for 6-months.
|
|
|
Contributor(s) |
Heikenwälder M, Kotsiliti E, Leone V, Unger K, Öllinger R, Rad R |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Dec 10, 2021 |
Last update date |
Dec 01, 2023 |
Contact name |
Kristian Unger |
E-mail(s) |
kristian.unger@med.uni-muenchen.de
|
Organization name |
LMU University Hospital
|
Department |
Department of radiation oncology
|
Lab |
AI-assisted therapy decisions in oncology
|
Street address |
Marchioninistr. 15
|
City |
Munich |
ZIP/Postal code |
81377 |
Country |
Germany |
|
|
Platforms (1) |
GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
|
Samples (29)
|
|
Relations |
BioProject |
PRJNA787962 |
SRA |
SRP350295 |